ЕРЛОТИНІБ-ВІСТА
Analogs of ЕРЛОТИНІБ-ВІСТА
Find cheaper analogs and generic equivalents for ЕРЛОТИНІБ-ВІСТА.
Active Ingredient: Erlotinib
Product Overview
About ЕРЛОТИНІБ-ВІСТА
ЕРЛОТИНІБ-ВІСТА is a prescription medication containing the active ingredient Erlotinib, a tyrosine kinase inhibitor. It is used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer.
Key Benefits & Uses
- Treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations
- Treatment of pancreatic cancer
- May be used in combination with other medications for the treatment of NSCLC and pancreatic cancer
Active Ingredient & Action
Erlotinib works by inhibiting the tyrosine kinase enzyme, which is involved in the signaling pathway that promotes cancer cell growth. By blocking this enzyme, Erlotinib helps to slow down the growth and spread of cancer cells.
Important Notes
ЕРЛОТИНІБ-ВІСТА should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and treatment schedule to minimize the risk of side effects. Patients with a history of liver or kidney disease, or those taking certain medications, should consult their doctor before starting treatment with ЕРЛОТИНІБ-ВІСТА.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
